+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

DelveInsight - Market Research Reports

Delve Insight authors market leading reports across the pharmaceutical and biotechnology sectors. The key findings and insights all come from regular monitoring of developments through the pharmaceutical and biotechnology sectors. These findings are then published through market forecasts, drug pipelines and drug insights, along with advice from top market analysts on how to best use this, alongside the detailed market forecasts offered by Delve Insight.

Erythropoietic Protoporphyria - Pipeline Insight, 2025 - Product Thumbnail Image

Erythropoietic Protoporphyria - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Fibrodysplasia Ossificans Progressive - Pipeline Insight, 2025 - Product Thumbnail Image

Fibrodysplasia Ossificans Progressive - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Gaucher Disease Type 1 - Pipeline Insight, 2025 - Product Thumbnail Image

Gaucher Disease Type 1 - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hypoxia - Pipeline Insight, 2025 - Product Thumbnail Image

Hypoxia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
IgG4-Related Disease - Pipeline Insight, 2025 - Product Thumbnail Image

IgG4-Related Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Infantile Neuroaxonal Dystrophy - Pipeline Insight, 2025 - Product Thumbnail Image

Infantile Neuroaxonal Dystrophy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Inherited Retinal Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Inherited Retinal Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Myelodysplastic Syndrome With Excess Blasts2 - Pipeline Insight, 2025 - Product Thumbnail Image

Myelodysplastic Syndrome With Excess Blasts2 - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Optic Nerve Diseases - Pipeline Insight, 2025 - Product Thumbnail Image

Optic Nerve Diseases - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pancreatic Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

Pancreatic Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 260 Pages
  • Global
From
Papilloma - Pipeline Insight, 2025 - Product Thumbnail Image

Papilloma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
PEComa - Pipeline Insight, 2025 - Product Thumbnail Image

PEComa - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Peripheral SpA - Pipeline Insight, 2025 - Product Thumbnail Image

Peripheral SpA - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Primary Hyperoxyaluria - Pipeline Insight, 2025 - Product Thumbnail Image

Primary Hyperoxyaluria - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Prostate Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

Prostate Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Prurigo Nodularis - Pipeline Insight, 2025 - Product Thumbnail Image

Prurigo Nodularis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Psoriasis Vulgaris- Pipeline Insight, 2025 - Product Thumbnail Image

Psoriasis Vulgaris- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Recurrent Herpes Labialis - Pipeline Insight, 2025 - Product Thumbnail Image

Recurrent Herpes Labialis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Stargardt Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Stargardt Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Loading Indicator